Lapatinib plus transtuzumab for HER-2 positiva metastatic breast cancer: Experience of use

• Main Authors: C. García-Muñoz (Author), S. Cortijo-Cascajares (Author), I. Cañamares-Orbis (Author), M. P. Goyache-Goñi (Author), J. M. Ferrari-Piquero (Author)
• Formato: Libro
• Publicado: Elsevier, 2014-03-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Abstract: Objective: To describe the outcomes produced by concomitant use of HER2-receptor inhibitors Lapatinib and Trastuzumab for the treatment of HER 2-positive metastatic breast cancer. Method: Retrospective observational study. Patients treated with Trastuzumab and Lapatinib between January of...